HOME >> BIOLOGY >> NEWS
The Cancer Genome Atlas awards funds for technology development

As part of The Cancer Genome Atlas (TCGA) pilot project, the National Institutes of Health (NIH) today awarded eight two-year grants totaling $3.4 million to support the development of innovative technologies for exploring the genomic underpinnings of cancer.

The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), both part of NIH, announced the TCGA pilot in December 2005 to test the feasibility of a large-scale, systematic approach to identifying the changes that occur in the genomes of cancer cells. The goal is to generate genomic information that the research community can use to develop new and improved strategies for detecting, treating and, ultimately, preventing cancer.

The types of tumors being studied in the pilot include brain cancer (glioblastoma), ovarian cancer and lung cancer (squamous cell), which together account for more than 200,000 cases of cancer in the United States each year.

In addition to the detailed genomic data it will generate, there is great hope that TCGA will both advance technological development and drive down its cost, said NCI Director John E. Niederhuber, M.D. Our greatest challenge will be in applying the volumes of information TCGA will provide about tumors to the genomic data NCI is gathering from large cohorts of patients, in order to better predict, and even prevent, the earliest development of cancer.

Cancer poses a very complex challenge. Each of the dozens of types of cancer likely will have a different genomic profile or set of profiles. We urgently need tools equal to this task, said NHGRI Director Francis S. Collins, M.D., Ph.D., whose institute led the NIH component of the Human Genome Project. One of the major lessons we learned from the Human Genome Project is that technology development is essential for success.

The institutions and principal investigators chosen to receive the two-year grants are:

  • Baylor
    '"/>


Contact: Geoff Spencer
spencerg@mail.nih.gov
301-402-0911
NIH/National Human Genome Research Institute
2-Jul-2007


Page: 1 2 3

Related biology news :

1. Journalists can register now for ECCO 14 -- the European Cancer Conference
2. Cancer cures could work for canines and humans
3. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
4. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
5. Cancer stem cells can go it alone
6. Cancer drug enhances long-term memory
7. Cancer cells reprogram energy needs to grow and spread, study suggests
8. Cancer scientists create human leukemia process to map how disease begins, progresses
9. Cancer tip -- Nanoparticles can damage DNA, increase cancer risk
10. Other highlights from the April 18 Journal of the National Cancer Institute
11. American Association for Cancer Research provides support for promising cancer scientists

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2020)... ... June 02, 2020 , ... ... barcode and RFID labeling software developer and solutions provider, today reported that ... improved labeling accuracy and compliance by 100%, resulting in greater efficiency for ...
(Date:5/28/2020)... ... May 27, 2020 , ... Today bioinformatics leader ... that uniquely combines lab testing insights and hc1’s exclusive Local Risk Index in ... and safety of employees returning to the workplace. , “Some of the best ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... solutions for biopharmaceutical R&D, today announced that Gritstone Oncology, Inc., a clinical-stage ... bispecific T cell engagers and TCR-based therapeutics, has implemented Genedata Biologics ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... , ... Kerafast Inc. , developers of an online ... of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by ... entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment. , ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., announced ... June 22-24 during the American Association for Cancer Research Virtual meeting. One poster ... potent, consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
(Date:6/11/2020)... HOUSTON (PRWEB) , ... June 08, 2020 , ... ... first universal vaccine platform delivered through the use of proprietary clean viral vectors, ... vaccine in the United States. Greffex’s platform is the world’s most successful ...
(Date:6/11/2020)... ... ... Reducing carbon emissions has been and will continue to be a major ... ways to reduce CO2 is something we can’t avoid. , To protect the ... produced today are created from recycled cooking oil or crops. Unfortunately, these sources are ...
Breaking Biology Technology:
Cached News: